Skip to main content

Animations

MJFF Publications

6381 - 6390 of 8666 Results
Title
Year
  • Year
  • 2017
  • 2019
  • 2019
  • 2021
  • 2025
  • 2022
  • 2019
  • 2021
  • 2017
  • 2018
  • Summary Details
    RESTRICTED
    Title: Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.13223
    Best OA location URL:
    Citation Count: 54
  • Summary Details
    OPEN
    Title: 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-019-0470-7
    Citation Count: 149
  • Summary Details
    OPEN
    Title: Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-42535-w
    Citation Count: 43
  • Summary Details
    OPEN
    Title: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/15548627.2021.1967615
    Citation Count: 41
  • Summary Details
    OPEN
    Title: A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70030
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson’s disease at 16q11.2 and MAPT H1 loci
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awac325
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra119.007743
    Citation Count: 114
  • Summary Details
    OPEN
    Title: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.abg3092
    Citation Count: 91
  • Summary Details
    OPEN
    Title: Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.28377
    Citation Count: 96
  • Summary Details
    OPEN
    Title: Tau immunoreactivity in peripheral tissues of human aging and select tauopathies
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2018.12.031
    Citation Count: 49
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.